Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00302666
Status:
COMPLETED
Last Update Posted:
2009-05-18
First Post:
2006-02-23
Brief Title:
Bleeding Pattern Study
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
Comparative Prospective Multi-Center Open Randomized Study to Investigate Bleeding Patterns Metabolic Effects Contraceptive Efficacy Acceptance and Safety of an Oral Contraceptive Containing 003 mg Ethinylestradiol and 2 mg Dienogest in Two Different Regimens of Intake Four Extended Cycles of 84 Days Each Versus the Conventional Regimen of 21 Days in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2009-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to evaluate bleeding pattern cycle control contraceptive efficacy and safety of this oral contraceptive in two different regimens of intake
Detailed Description:
The study has previously been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer Schering Pharma AG Germany
Bayer Schering Pharma AG Germany is the sponsor of the trial
Bayer Schering Pharma AG Germany is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 306903 | None | None | None |